Chemerin is associated with markers of inflammation and components of the metabolic syndrome but does not predict coronary atherosclerosis

被引:258
|
作者
Lehrke, Michael [1 ]
Becker, Alexander [2 ]
Greif, Martin [2 ]
Stark, Renee [3 ]
Laubender, Ruediger P. [4 ]
von Ziegler, Franz [2 ]
Lebherz, Corinna [2 ]
Tittus, Janine [2 ]
Reiser, Maximilian [5 ]
Becker, Christoph [5 ]
Goeke, Burkhard [1 ]
Leber, Alexander W. [2 ]
Parhofer, Klaus G. [1 ]
Broedl, Uli C. [1 ]
机构
[1] Univ Munich, Dept Internal Med 2, D-81377 Munich, Germany
[2] Univ Munich, Dept Internal Med 1, D-81377 Munich, Germany
[3] Helmholtz Zentrum, Munich, Germany
[4] Univ Munich, Inst Med Informat Biometry & Epidemiol, Munich, Germany
[5] Univ Munich, Dept Radiol, Munich, Germany
关键词
ADIPOKINE; ADIPOCYTE;
D O I
10.1530/EJE-09-0380
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives: Chemerin is a recently discovered adipokine that regulates adipocyte differentiation and modulates chemotaxis and activation of dendritic cells and macrophages. Given the convergence of adipocyte and macrophage function, chemerin may provide an interesting link between obesity. inflammation and atherosclerosis in humans. We sought to examine the relationship of i) chemerin and markers of inflammation, ii) chemerin and components of the metabolic syndrome. and iii) chemerin and coronary atherosclerotic plaque burden and morphology. Design: Serum chemerin levels were determined in 303 patients with stable typical or atypical chest Pain Who Underwent dual-source multi-slice CT-angiography to exclude coronary artery stenosis. Atherosclerotic plaques were classified its calcified, mixed. or non-calcified. Results: Chemerin levels were highly correlated with high sensitivity C-reactive protein (r=0.44. P<0.0001). interleukin-6 (r=0.18, P=0.002), tumor necrosis factor-alpha. (r=0.24, P<0.0001). resistin (r=0.28. P<0.0001), and leptin r=0.36. P<0.0001) concentrations. Furthermore, chemerin was associated with components of the metabolic syndrome including body mass index (r=0.23, P=0.0002). triglycerides (r=0.29. P<0.0001), HDL-cholesterol (r=-0.18, P=0.003). and hypertension (P<0.0001). In bivariate analysis. chemerin levels were weakly correlated with coronary plaque burden (r=0.16. P=0.006) and the number of non-calcified plaques (r=0.14. P=0.02). These associations, however, were lost after adjusting for established cardiovascular risk factors (odds ratio. OR 1.17, 95%, confidence interval (Cl) 0.97-1.41. P=0.11 for coronary plaque burden: OR 1.06, 95% Cl 0.96-1.17. P=0.22 for non-calcified plaques). Conclusions: Chemerin is strongly associated with markers of inflammation and components of the metabolic syndrome. However, chemerin does not predict coronary, atherosclerosis.
引用
收藏
页码:339 / 344
页数:6
相关论文
共 50 条
  • [11] Subclinical inflammation, the metabolic syndrome, and coronary atherosclerosis in men and women
    Rein, P.
    Saely, C. H.
    Beer, S.
    Vonbank, A.
    Boehnel, C.
    Jankovic, V.
    Drexel, H.
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2011, 41 : 69 - 69
  • [12] Subclinical inflammation, the metabolic syndrome, and coronary atherosclerosis in men and women
    Rein, P.
    Saely, C. H.
    Vonbank, A.
    Beer, S.
    Boehnel, C.
    Jankovic, V.
    Breuss, J.
    Drexel, H.
    EUROPEAN HEART JOURNAL, 2010, 31 : 1011 - 1011
  • [13] Associations of serum uric acid with markers of inflammation, metabolic syndrome, and sub-clinical coronary atherosclerosis
    Coutinho, Thais de A.
    Turner, Stephen T.
    Peyser, Patricia A.
    Bielak, Lawrence F.
    Sheedy, Patrick F.
    Kullo, Iftikhar J.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2007, 49 (09) : 317A - 317A
  • [14] Markers of antiphospholipid syndrome are strongly associated with coronary atherosclerosis
    Burazor, Ivana
    Vojdani, Aristo
    Burazor, Mirko
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2008, 28 (06) : E69 - E69
  • [15] Subclinical Inflammation, the Metabolic Syndrome, and Coronary Atherosclerosis in Men and Women
    Beer, Stefan
    Rein, Philipp
    Saely, Christoph H.
    Vonbank, Alexander
    Boehnel, Christian
    Jankovic, Vlado
    Breuss, Johannes
    Muendlein, Axel
    Drexel, Heinz
    DIABETES, 2010, 59 : A217 - A217
  • [16] Subclinical inflammation, the metabolic syndrome, and coronary atherosclerosis in men and women
    Rein, Philipp
    Saely, Christoph
    Beer, Stefan
    Vonbank, Alexander
    Drexel, Heinz
    WIENER KLINISCHE WOCHENSCHRIFT, 2010, 122 (17-18) : A27 - A27
  • [17] Inflammation markers are associated with metabolic syndrome and ventricular arrhythmia in patients with coronary artery disease
    Safranow, Krzysztof
    Dziedziejko, Violetta
    Rzeuski, Ryszard
    Czyzycka, Edyta
    Bukowska, Hanna
    Wojtarowicz, Andrzej
    Binczak-Kuleta, Agnieszka
    Jakubowska, Katarzyna
    Olszewska, Maria
    Ciechanowicz, Andrzej
    Kornacewicz-Jach, Zdzislawa
    Machalinski, Boguslaw
    Pawlik, Andrzej
    Chlubek, Dariusz
    POSTEPY HIGIENY I MEDYCYNY DOSWIADCZALNEJ, 2016, 70 : 56 - 66
  • [18] Chemerin is not associated with subclinical atherosclerosis markers in prediabetes and diabetes
    Aydin, Kadriye
    Canpolat, Ugur
    Akin, Safak
    Dural, Muhammet
    Karakaya, Jale
    Aytemir, Kudret
    Ozer, Necla
    Gurlek, Alper
    ANATOLIAN JOURNAL OF CARDIOLOGY, 2016, 16 (10): : 749 - 755
  • [19] Influence of inflammation and adipocyte biochemical markers on the components of metabolic syndrome
    Carmen Zaha, Dana
    Vesa, Cosmin
    Uivarosan, Diana
    Bratu, Ovidiu
    Fratila, Ovidiu
    Mirela Tit, Delia
    Pantis, Carmen
    C. Diaconu, Camelia
    Bungau, Simona
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2020, 20 (01) : 121 - 128
  • [20] Metabolic syndrome, inflammation and atherosclerosis
    Paoletti, Rodolfo
    Bolego, Chiara
    Poli, Andrea
    Cignarella, Andrea
    VASCULAR HEALTH AND RISK MANAGEMENT, 2006, 2 (02) : 145 - 152